PubMed:19445921 / 1204-1401 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T9","span":{"begin":0,"end":197},"obj":"Sentence"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-entities","denotations":[{"id":"6063","span":{"begin":18,"end":36},"obj":"ChemicalEntity"},{"id":"6064","span":{"begin":85,"end":98},"obj":"ChemicalEntity"},{"id":"6065","span":{"begin":107,"end":126},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6066","span":{"begin":131,"end":148},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A23","pred":"db_id","subj":"6063","obj":"MESH:C066201"},{"id":"A24","pred":"db_id","subj":"6064","obj":"MESH:D007545"},{"id":"A25","pred":"db_id","subj":"6065","obj":"MESH:D006331"},{"id":"A26","pred":"db_id","subj":"6066","obj":"MESH:D009202"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T3","span":{"begin":142,"end":148},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0021178"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T21","span":{"begin":30,"end":34},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":43,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":74,"end":84},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":99,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":162,"end":175},"obj":"GeneOrGeneProduct"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T14","span":{"begin":30,"end":34},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":43,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":74,"end":84},"obj":"GeneOrGeneProduct"},{"id":"T17","span":{"begin":162,"end":175},"obj":"GeneOrGeneProduct"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T3","span":{"begin":107,"end":126},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":142,"end":148},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"originalLabel","subj":"T3","obj":"DISEASE"},{"id":"A4","pred":"originalLabel","subj":"T4","obj":"D014947"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T7","span":{"begin":43,"end":49},"obj":"GeneOrGeneProduct"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T3","span":{"begin":142,"end":148},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0021178"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":107,"end":126},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":142,"end":148},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"ID:","subj":"T5","obj":"D014947"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":107,"end":126},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":131,"end":148},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"#label","subj":"T5","obj":"EisukeAdded"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T22","span":{"begin":18,"end":34},"obj":"ChemicalEntity"},{"id":"T23","span":{"begin":85,"end":98},"obj":"ChemicalEntity"}],"attributes":[{"id":"A22","pred":"ID:","subj":"T22","obj":"C568740"},{"id":"A23","pred":"ID:","subj":"T23","obj":"D007545"},{"id":"A24","pred":"ID:","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_64317"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T23","span":{"begin":85,"end":98},"obj":"ChemicalEntity"},{"id":"T22","span":{"begin":18,"end":34},"obj":"ChemicalEntity"},{"id":"T91268","span":{"begin":43,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T52736","span":{"begin":131,"end":148},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T45172","span":{"begin":107,"end":126},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A24","pred":"ID:","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_64317"},{"id":"A23","pred":"ID:","subj":"T23","obj":"D007545"},{"id":"A22","pred":"ID:","subj":"T22","obj":"C568740"},{"id":"A90905","pred":"#label","subj":"T52736","obj":"EisukeAdded"},{"id":"A43730","pred":"#label","subj":"T45172","obj":"DISEASE"}],"text":"Administration of salvianolic acid A for a period of 8 days significantly attenuated isoproterenol-induced cardiac dysfunction and myocardial injury and improved mitochondrial respiratory function."}